CTRI/2024/07/070582
Not yet recruiting
未知
Efficacy and Safety of use of Dexmedetomidine with Fentanyl versus Dexmedetomidine for Hypotensive anaesthesia in patients undergoing functional endoscopic sinus surgery - Nil
Dr Sridevi Mulimani0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Sridevi Mulimani
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 ASA GRADE 1\&2
- •2 age group 18\-60 years
- •3\.patients undergoing FESS surgery \[elective]
Exclusion Criteria
- •Age\-less than 17 years and greater than 60 years,male and female
- •Pregnant women
- •Beta blockers taking patients
- •Hemodynamically unstable patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Evaluation of dexmedetomidine in reducing postoperative ocular paiIRCT20200503047291N1Mashhad University of Medical Sciences30
Recruiting
Phase 3
Evaluation of the effectiveness of dexmedetomidineine sedation of COVID-19 critically ill patientsIRCT20110425006280N13Vice President of Research Guilan university of medical sciences60
Completed
Phase 1
Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoringSpinal cord tumors, spinal disordersJPRN-UMIN000009044iigata University Medical and Dental Hospital, Anesthesiology10
Recruiting
Phase 2
Evaluation of Dexmedetomidine effect on mentally-disabled adults, candidate for dental treatment under general aneasthesiaIRCT20190626044013N2Esfahan University of Medical Sciences50
Active, not recruiting
Not Applicable
The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks (regional anesthesia) for shoulder surgeryThe goal of the present study is to investigate the safety and efficiacy of dexmedetomidine added toropivacaine for interscalene brachial plexus nerve block for shoulder surgery in humans.Provided the initial safety can be established, the trial will continue to evaluate secondary goalsincluding the duration of analgesia, onset of sensory and motor blockade, and opioid-inducedside effects. Tertiary outcomes will include activity, sleep, and subject satisfaction.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2011-002175-42-ATParacelsus Medizinische Universität - Universitätsklinik für Anästhesie